U.S. states sue opioid-maker Indivior, alleging anticompetitive practices

11:54 EDT 22 Sep 2016 | Yahoo News

By Sarah N. Lynch WASHINGTON (Reuters) - Thirty-five U.S. states and the District of Columbia filed a lawsuit on Thursday against opioid drug maker Indivior alleging it tried to keep generic versions of a drug off the market. British-based Indivior, which was spun off from Reckitt Benckiser in 2014, is the maker of Suboxone, a drug used to treat patients addicted to heroin and other painkillers. The lawsuit by the states alleged that Indivior took steps to get patients to switch to a dissolvable oral strip version of Suboxone.

Original Article: U.S. states sue opioid-maker Indivior, alleging anticompetitive practices


More From BioPortfolio on "U.S. states sue opioid-maker Indivior, alleging anticompetitive practices"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...